Latest Headlines
September 27, 2024
CABINET Trial Supports Multitargeted Tyrosine Kinase Inhibitor for Advanced Neuroendocrine Tumors
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
September 27, 2024
Written testimony for House of Delegates reference committee hearings due Oct. 14
ADA News
September 27, 2024
Community-Academic Partnership May Successfully Reduce Radon-Related Lung Cancer Risk in Native Population
The ASCO Post
Advertisement
Recommendations
Advertisement